Collaborative Alliance for Drug Discovery

LSH and TüCAD2 of the University of Tübingen have formed a collaborative alliance. TüCAD2 is the leading academic drug discovery center in Germany, supported by the Excellence Initiative, with an outstanding track record of drug candidates in clinical trials. The collaborative efforts concentrate on protein kinase drug discovery, with data analytics and ML/XAI carried out in Bonn and compound synthesis, biological testing, and pharmacology conducted in Tübingen. LSH milestone projects such as this alliance substantially support and further increase the interdisciplinary orientation of the Lamarr Institute.